One community health center in Wisconsin has said that under the proposed pilot program, their upfront drug costs would increase by 2,360%, threatening their financial stability and, of course, patient care. I've heard similar concerns from Hospitals, particularly from rural hospitals, would struggle with millions more in additional upfront costs under a pilot program as proposed. Dr. Feldman, how would a rebate model change the operation of the 340B program? And what would the impact of this shift be on providers and on patients? (00:54–01:09)
CLAIM
Asserts that rural hospitals would face significant financial challenges due to increased upfront costs under the proposed pilot program.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
